GLP-1 weight-loss plateaus: why they happen, and what the evidence says to do

Weight loss slowing down or stopping on a GLP-1 feels like the medication has stopped working. In most cases, that's not quite what's happening — it's your body responding to weight loss the way it's built to, and the physiology behind it is well documented, if not always intuitive.

The physiology: your body fights back

As you lose weight, your energy expenditure drops — a smaller body simply needs fewer calories to maintain itself, and metabolic adaptation can push that drop beyond what body-size changes alone would predict, a phenomenon well described in the underfeeding and weight-loss-maintenance literature²¹. At the same time, appetite-regulating hormones shift in ways that tend to push back against continued loss. A GLP-1 counteracts part of that hormonal pushback, which is exactly why these drugs work as well as they do — but it doesn't eliminate the energy-expenditure side of the equation. Eventually, calories burned and calories consumed converge again, and the scale stalls. This is a predictable equilibrium, not a sign the drug has failed.

Muscle's role in the plateau

Recent research has connected this directly to body composition: work examining how muscle mass interacts with GLP-1 receptor signaling suggests that preserving lean mass during treatment may help offset some of the metabolic slowdown that drives a plateau, since muscle is metabolically active tissue that contributes to how many calories your body burns at rest³. That's a big part of why preserving muscle isn't just a cosmetic concern — see preventing muscle loss on a GLP-1 for what the evidence supports doing about it specifically.

What a plateau doesn't mean

A stall doesn't necessarily mean you need a higher dose, a different drug, or that something has gone wrong. It's also worth separating a genuine plateau from a temporary stall — weight fluctuates day to day and week to week from water retention, sodium intake, and hormonal cycles, and a few flat weeks is not the same as a true multi-month plateau. Give any apparent stall a real window — several weeks, not several days — before treating it as one.

What the evidence actually supports doing

A recent narrative review on weight-loss plateaus lays out the realistic options once a genuine plateau is confirmed: reassessing dietary intake (calorie needs genuinely drop as you lose weight, so an intake that created a deficit at a higher body weight may no longer), increasing physical activity (particularly resistance training, for the reasons above), and, where clinically appropriate, discussing a dose adjustment with your prescriber⁴. None of these are guaranteed to restart rapid loss, and that's an important expectation to set — a plateau after significant loss is sometimes simply your body's new, appropriate equilibrium, not a problem to be solved at all costs.

When to loop in your prescriber

If you're still titrating and plateau early, that's a different conversation than plateauing after months at a stable maintenance dose — your prescriber may have room to adjust the dose within your titration schedule; see semaglutide dosing and titration and tirzepatide dosing and titration for how that schedule works. If you've been at maintenance for a long stretch and progress has genuinely stopped, it's worth discussing directly rather than assuming nothing can be done — or accepting that this may be a reasonable place to stabilize. This also connects to a bigger decision many people eventually face: whether to continue treatment long-term or stop, which carries its own well-documented regain risk — see stopping a GLP-1: regain risk, explained. And the plateau sits within the broader arc covered in our weight-loss timeline. This is general information, not a substitute for a conversation with your prescriber about your specific progress.